Clinical Trial Update: Study of IRNEA (Irinotecan, Etoposide, Cytarabine) for Refractory or Relapsed Acute Leukemia in Children and Adolescents [Phase 1]

View source ↗

Summary

This entry describes a Phase 1 clinical trial evaluating IRNEA (Irinotecan, Etoposide, Cytarabine) for children and adolescents with refractory or relapsed acut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Etoposide (Etoposide)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Acute Leukemia | Phase 1 | Status: UNKNOWN